Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease

被引:5
作者
Rudd, Michael T. [1 ]
McCauley, John A. [1 ]
Romano, Joseph J. [1 ]
Butcher, John W. [1 ]
Bush, Kimberly [1 ]
McIntyre, Charles J. [1 ]
Nguyen, Kevin T. [1 ]
Gilbert, Kevin F. [1 ]
Lyle, Terry A. [1 ]
Holloway, M. Katharine [4 ]
Wan, Bang-Lin [3 ]
Vacca, Joseph P. [1 ]
Summa, Vincenzo [5 ]
Harper, Steven [5 ]
Rowley, Michael [5 ]
Carroll, Steven S. [2 ]
Burlein, Christine [2 ]
DiMuzio, Jillian M. [2 ]
Gates, Adam [2 ]
Graham, Donald J. [2 ]
Huang, Qian [2 ]
Ludmerer, Steven W. [2 ]
McClain, Stephanie [2 ]
McHale, Carolyn [2 ]
Stahlhut, Mark [2 ]
Fandozzi, Christine [3 ]
Taylor, Anne [3 ]
Trainor, Nicole [3 ]
Olsen, David B. [2 ]
Liverton, Nigel J. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
[2] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA
[4] Merck Res Labs, Chem Modeling & Informat, West Point, PA 19486 USA
[5] Merck Res Labs, IRBM, Dept Med Chem, Rome, Italy
关键词
Hepatitis C; NS3/4A protease; Macrocycle; Alkoxyquinoline; P2-P4; linker; HEPATITIS-C VIRUS; PRECLINICAL PROFILE; DISCOVERY; REPLICATION; TMC435350; MK-5172;
D O I
10.1016/j.bmcl.2012.08.106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of macrocyclic compounds containing 2-substituted-quinoline moieties have been discovered and shown to exhibit excellent HCV NS3/4a genotype 3a and genotype 1b R155K mutant activity while maintaining the high rat liver exposure. Cyclization of the 2-substituted quinoline substituent led to a series of tricyclic P2 compounds which also display superb gt3a potency. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7201 / 7206
页数:6
相关论文
共 32 条
[1]   Novel dipeptide macrocycles from 4-oxo, -thio, and -amino-substituted proline derivatives [J].
Arasappan, A ;
Chen, KX ;
Njoroge, FG ;
Parekh, TN ;
Girijavallabhan, V .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (11) :3923-3926
[2]   DISPLACEMENT OF PROTOMERIC EQUILIBRIA BY SELF-ASSOCIATION - HYDROXYPYRIDINE-PYRIDONE AND MERCAPTOPYRIDINE-THIOPYRIDONE ISOMER PAIRS [J].
BEAK, P ;
COVINGTON, JB ;
SMITH, SG ;
WHITE, JM ;
ZEIGLER, JM .
JOURNAL OF ORGANIC CHEMISTRY, 1980, 45 (08) :1354-1362
[3]  
Cacchi S., 1997, SYNLETT, V12, P1400
[4]  
Chen KX, 2009, CURR OPIN INVEST DR, V10, P821
[5]  
Fried M, 2002, AM POETRY REV, V31, P36
[6]  
GONZALEZ R, 1993, HETEROCYCLES, V36, P315
[7]   Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose [J].
Hadziyannis, SJ ;
Sette, H ;
Morgan, TR ;
Balan, V ;
Diago, M ;
Marcellin, P ;
Ramadori, G ;
Bodenheimer, H ;
Bernstein, D ;
Rizzetto, M ;
Zeuzem, S ;
Pockros, PJ ;
Lin, A ;
Ackrill, AM .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :346-355
[8]   Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor [J].
Harper, Steven ;
McCauley, John A. ;
Rudd, Michael T. ;
Ferrara, Marco ;
DiFilippo, Marcello ;
Crescenzi, Benedetta ;
Koch, Uwe ;
Petrocchi, Alessia ;
Holloway, M. Katharine ;
Butcher, John W. ;
Romano, Joseph J. ;
Bush, Kimberly J. ;
Gilbert, Kevin F. ;
McIntyre, Charles J. ;
Nguyen, Kevin T. ;
Nizi, Emanuela ;
Carroll, Steven S. ;
Ludmerer, Steven W. ;
Burlein, Christine ;
DiMuzio, Jillian M. ;
Graham, Donald J. ;
McHale, Carolyn M. ;
Stahlhut, Mark W. ;
Olsen, David B. ;
Monteagudo, Edith ;
Cianetti, Simona ;
Giuliano, Claudio ;
Pucci, Vincenzo ;
Trainor, Nicole ;
Fandozzi, Christine M. ;
Rowley, Michael ;
Coleman, Paul J. ;
Vacca, Joseph P. ;
Summa, Vincenzo ;
Liverton, Nigel J. .
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (04) :332-336
[9]  
HOLLOWAY MK, 2006, Patent No. 2006119061
[10]  
Hughes D.L., 1992, ORG REACT, V42, P335, DOI DOI 10.1002/0471264180.0R042.02